Please see full Prescribing Information, including Boxed WARNING and Medication Guide at the "Learn more" link above or here: https://qr.qrhub.ly/VANPI.
VANRAFIA is a Novartis Pharmaceuticals Corporation product and is not associated with any individual users on LinkedIn. This information is for US health care professionals only.
To report suspected adverse reactions, contact Novartis Pharmaceuticals Corporation at 1-888-669-6682 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
This page is sponsored by Novartis Pharmaceuticals Corporation.
4/25 FA-11239039
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.vanrafia-hcp.com
Vanrafia® (Atrasentan) For Us Hcps Questions
Vanrafia® (Atrasentan) For Us Hcps's website is https://www.vanrafia-hcp.com
Vanrafia® (Atrasentan) For Us Hcps's LinkedIn profile is https://www.linkedin.com/company/vanrafia-hcp
Vanrafia® (Atrasentan) For Us Hcps's industry is
Pharmaceutical Manufacturing
Vanrafia® (Atrasentan) For Us Hcps's top competitors are
Novartis,
Eli Lilly And Company,
Amgen,
Boehringer Ingelheim,
Guardant Health,
Madrigal Pharmaceuticals,
Tg Therapeutics, Inc.,
Akebia Therapeutics,
Xeris Pharmaceuticals, Inc.,
Pelthos Therapeutics.
Vanrafia® (Atrasentan) For Us Hcps's categories are Pharmaceutical Manufacturing
